NUPHAR LUTEA EXTRACT INHIBITS THE NF-KB PATHWAY, POTENTIATES APOPTOSIS, IS SYNERGISTIC WITH CHEMOTHERAPY AND HAS ANTI-METASTATIC ACTIVITY

Jacob Gopas 1 Janet Ozer 2 Levi Tal 2 Benharoch Daniel 3 Avi Golan-Goldhirsh 4
1Microbiology and Immunology and the Research Laboratory of Oncology Department, Ben Gurion University and Soroka University Medical Center, Beer Sheva
2Microbiology and Immunology, Ben Gurion University, Beer Sheva
3Pathology, Ben Gurion University and Soroka University Medical Center, Beer Sheva
4Albert Katz Department of Dryland Biotechnologies, Ben Gurion University, Sde Boker Campus, Sde Boker

We screened thirty-four methanolic plant extracts for inhibition of constitutive nuclear factor κB (NF- κB) activity by a NF- κB-luciferase reporter gene assay. Strong inhibition of NF- κB activity was found in extracts of leaf and rhizome from Nuphar lutea L. SM. (Nuphar). Dimeric sesquiterpene thioalkaloids were found to be the major components of the partially purified extract. The nuphar alkaloids mixture (NUP) showed a dose dependent inhibition of NF-κB activity in a luciferase reporter gene assay as well as reduction of nuclear NF-κB subunits expression as tested by western blots and immuno-histochemistry. Decreased DNA binding was demonstrated in Electro Mobility Shift Assays (EMSA). NUP inhibited both inducible and constitutive NF-κB activation and affected the canonical and alternative pathways. Suppression of NF- κB was not cell type specific. Induction of apoptosis by the alkaloid mixture was demonstrated by time-dependent and dose-dependent cleavage of procaspase-9 and PARP. Synergistic cytotoxicity of the active mixture with cisplatin and etoposide was demonstrated (1). In addition, in vivo experiments demonstrated that NUP partially protected mice from LPS- induced septic shock and from experimental B16 melanoma lung metastasis. Overall, our results show that NUP inhibits the NF-κB pathway and acts as a sensitizer to conventional chemotherapy, enabling the search for its specific target and its application against cancer and inflammation.

(1) Ozer et al. Cancer Biology & Therapy. 8:1860-1868; 2009. Commented in

Efferth T. Cancer Biology & Therapy 8:1869-1870; 2009








 




Powered by Eventact EMS